Read the Latest News
or Download our Publications.

14. June 2022

Dr. Aran receives research gift from Agilent Technologies to develop real-time monitoring of cell cultures using Cardea’s BPU platform

San Diego, California -- June 14, 2022 -- Dr. Kiana Aran, Associate Professor of Medical...
Read more

7. June 2022

From CPUs to BPUs - a new generation of biocompatible semiconductors for rapid amplification-free genotyping being introduced at AGBT

San Diego, CA and Orlando, FL -- June 7, 2022 -- Today, at the prestigious Advances in Genome...
Read more

7. June 2022

AGBT 2022 abstract by Dr. Kiana Aran: From CPUs to BPUs : a new generation of transistors for rapid amplification-free genotyping

Introducing the first-generation DNA targeted BPUs that combine CRISPR technology with the...
Read more

3. May 2022

Cardea Bio receives funding to develop electronic nose to rapidly diagnose infectious diseases via breath

Today, Cardea Bio, Inc. - the world's only mass producer of biocompatible semiconductors -...
Read more

27. April 2022

Securing international patents for mass-produced graphene biosensors

Today, Cardea Bio, Inc. - the world's first mass producer of graphene biosensors - shares their...
Read more

5. April 2022

Cardea Bio completes planned launch of CRISPR QC

San Diego, CA -- April 5, 2022 -- Today, Cardea Bio, Inc. - the world’s only mass producer of...
Read more

8. March 2022

Nature Awards Webcasts: Kiana Aran and the future of CRISPR technology

An exciting and inspiring session with our Chief Scientific Officer, Kiana Aran, on the future of...
Read more

2. February 2022

Dr. Kiana Aran Receives NIH Funding to Help Set Quality Control Standards for CRISPR Therapies

Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics and head of the Aran...
Read more

10. January 2022

Cardea announces a collaboration agreement with Siemens Healthineers to assess feasibility of real-time applications

San Diego, CA -- January 10, 2022 -- Today, Cardea Bio, Inc. - the world’s only mass producer of...
Read more

9. December 2021

Cardea Bio accelerates commercial platform due to demand from market moving partners

To signal that Cardea Bio, Inc. is investing significantly into the commercialization efforts of...
Read more